REXONAGE3 · QMR TECHNOLOGY

A different approach
to regeneration.

Work with the skin’s natural potential.

Discover non-thermal Quantum Molecular Resonance. A professional treatment platform designed to support skin quality and regenerative treatment pathways.

Explore the science

UK & Ireland provider

Rexonage3 device with touchscreen, treatment accessories and integrated trolley

Rexonage3QMR technology by Telea Medical

Non-thermalWithout deliberate thermal injury

Face & bodyAdaptable treatment accessories

Local expertiseUK & Ireland training and support

Professional Rexonage3 treatment on the cheek, with the patient reclining beside the device — THE REXONAGE3 EXPERIENCEConsidered treatment.
Human touch.

A CELLULAR PERSPECTIVE

Support skin quality.
Respect tissue integrity.

A broad spectrum of high-frequency electrical energy, designed to work without deliberate thermal injury.

Rexonage3 delivers Quantum Molecular Resonance through a choice of treatment accessories. It is designed to support the tissue environment and the skin’s natural regenerative processes.

Beyond a heating responseQMR is designed around biological stimulation, rather than intentional thermal damage.

Research at the cellular levelStudies explore cellular signalling, inflammatory pathways and extracellular-matrix remodelling.

Adapted to the individualAccessories and protocols are selected around the patient, treatment area and clinical assessment.

Explore the research and its context

BENEATH THE SURFACE

The tissue environment.
A closer look.

These illustrations show the concept behind QMR: influencing cellular activity and supporting the environment in which tissue renewal takes place.

Manufacturer schematic of the tissue environment before QMR therapy — BEFORE THERAPY
Understand the starting point.
Skin quality reflects the behaviour of cells, collagen and the surrounding extracellular matrix.

Manufacturer schematic illustrating QMR energy interacting with tissue during therapy — DURING THERAPY
Explore biological stimulation.
QMR delivers a spectrum of electrical frequencies. Research examines the cellular pathways affected by this exposure.

Manufacturer conceptual illustration of the intended tissue environment following QMR therapy — THE TREATMENT AIM
Support tissue quality.
The aim is to support the tissue environment and skin quality through a personalised course of treatment.

Images for illustration purposes only.

ONE PLATFORM. DIFFERENT SKIN PRIORITIES.

Rexonage3
applications.

Explore Rexonage3 applications for skin quality, inflammatory skin concerns, scarring and post-procedure support. A practitioner’s assessment, current guidance and the evidence for each concern determine suitability.

Skin quality & ageing

A non-invasive option for clinics exploring the appearance of fine lines, skin laxity and uneven texture.

Face, neck and selected body areas
Texture and visible signs of ageing
Protocols shaped around individual skin quality

Inflammatory skin concerns

Rexonage3 applications include selected inflammatory skin concerns, such as acne-prone skin and redness. Diagnosis and clinical suitability come first; the evidence differs by condition.

Q-Flow and Q-Roller are not used within inflammatory skin protocols.

Scars & uneven texture

Discuss a treatment pathway for the appearance of acne scars, selected surgical scars and uneven skin texture. Scar type, healing stage and the patient’s wider care plan guide the approach.

Post-procedure support

QMR has been investigated as an adjunct after rhinoseptoplasty, including the duration of postoperative swelling and bruising. The treating clinician determines timing and suitability.

See the human study

Rexonage3 contact treatment around the jaw and neck — A personalised approach to face, neck and skin quality.

PRECISION IN YOUR HANDS

The right touch.
For the right area.

Five ways to work with QMR. Discover the accessories and discuss the configuration that fits your practice.

Practitioner delivering QMR through the Q-Touch treatment gloves

Q-TOUCH GLOVES

Technology meets
the human touch.

Hands-on QMR delivery through massage-style movements, shaped around facial contours and selected treatment areas.

The gloves bring a tactile, therapist-led approach to treatment, allowing the practitioner to adapt contact and movement to the area.

Explore the manufacturer’s tissue and accessory illustration

Manufacturer diagram showing the Rexonage3 accessories and their schematic relationship to tissue layers — Telea Medical manufacturer illustration. Schematic, not to scale; this is not a measured penetration-depth chart. Treatment choice follows the current protocol.

Accessories supplied depend on the configuration selected. Beautyform will confirm the equipment included in your quotation.

IN PRACTICE

See the approach.
Feel the difference.

Explore Rexonage3 in the video, then arrange a demonstration with Beautyform to experience the platform first-hand.

THE EVIDENCE, IN CONTEXT

Explore the
QMR research.

A concise introduction to selected publications. Request the papers to examine the methods, findings and relevance to your clinical practice.

These studies span QMR platforms and experimental settings. They are not all clinical trials of Rexonage3.

HUMAN COMPARATIVE STUDY2022

QMR after rhinoseptoplasty.

A 60-patient comparative study reported shorter mean duration of swelling and bruising in the QMR group than with conventional icepack care.

60patients
30 in each group

2.0 vs 4.6days of mean oedema duration
QMR vs icepack care

A specific postoperative setting. This does not establish the same effect across every device, procedure or patient.

Ahn et al. · Journal of Cosmetic Dermatology · 21:3530–3536.
DOI: 10.1111/jocd.14628

LABORATORY STUDY2023

Investigating inflammatory pathways.

Research in a macrophage model found changes in inflammatory signalling and a shift towards an M2 phenotype after QMR exposure.

Cell-model findings help explain a possible mechanism. They do not establish treatment outcomes in patients with inflammatory skin conditions.

Paolucci et al. · Antioxidants · 12:1358.
DOI: 10.3390/antiox12071358

LABORATORY STUDY2018

Exploring cellular signalling.

A study in human mesenchymal stromal cells identified changes in genes linked to extracellular-matrix remodelling.

Cell viability, proliferation and differentiation remained unchanged. This was a laboratory study, not a clinical skin-rejuvenation trial.

Sella et al. · PLOS ONE · 13:e0190082.
DOI: 10.1371/journal.pone.0190082

PRECLINICAL STUDY2025

Early research in inflammatory skin.

A mouse-model study explored QMR in dermatitis-like skin inflammation, alongside experiments in human keratinocytes.

These are early biological findings. They do not establish efficacy for treating atopic dermatitis in people.

Kim et al. · BMB Reports · 58:209–216.
DOI: 10.5483/BMBRep.2024-0105

Take a closer look at the literature.

Share your clinic details and our team will help you access the relevant papers.

A CLEARER PICTURE

Your questions.
Considered answers.

Have a question about a particular patient group, protocol or accessory? Speak with our team.

Talk to Beautyform

How does QMR differ from conventional RF?

Both involve high-frequency electrical energy. Rexonage3 uses a broad QMR frequency spectrum and is designed to work without deliberate thermal injury. It should be explained through its own operating principles and protocols; radiofrequency technologies vary in how they deliver energy.

What does a treatment feel like?

Rexonage3 is a non-invasive treatment designed with patient comfort in mind. The sensation depends on the accessory and settings; Q-Touch gloves may produce a sensation of warmth. A demonstration helps practitioners understand the different techniques.

How is a treatment course planned?

The practitioner assesses the concern, treatment area, medical history and suitability before selecting a protocol. The course and review points follow current manufacturer guidance and professional training.

Can Rexonage3 complement other treatments?

QMR has been explored in adjunctive and postoperative settings. Combination treatments require a clinician-led plan, appropriate timing and review of the instructions for each procedure. The available evidence is specific to the protocols studied.

How do I access the clinical papers?

Select “Request clinical papers” or a paper card, then complete the short pop-up form. The Beautyform team will contact you with the relevant literature and can help you interpret its relevance to your practice.

YOUR NEXT STEP

Bring a new perspective
to your practice.

Explore Rexonage3 with Beautyform Medical, your UK & Ireland provider. Arrange a demonstration, discuss the right configuration and discover our training and ongoing support.

Product demonstrationProfessional trainingOngoing local support

0330 122 0879 info@beautyform.co.uk121 Gloucester Place, Marylebone, London W1U 6JY

Rexonage3 professional treatment platform in its manufacturer studio — REXONAGE3
Powered by QMR. Supported by Beautyform.

For professional use. Clinical suitability, treatment settings and contraindications follow current instructions and professional training.

A different approach
to regeneration.

Support skin quality.
Respect tissue integrity.

The tissue environment.
A closer look.

Understand the starting point.

Explore biological stimulation.

Support tissue quality.